EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients ...
Austin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Asthma and COPD Drugs Market Size & Growth Outlook According to SNS Insider, the global Asthma and COPD Drugs Market is estimated at USD 33.16 billion in 2025 ...
Kymera drug positioned to rival Sanofi and Regeneron’s Dupixent succeeds in early-stage eczema trial
Now, the company will aim to show the drug helps patients with eczema and asthma in larger, placebo-controlled trial.
Glenmark Pharma launches Nebzmart GFB & Airz FB Smartules, a fixed-dose triple therapy for COPD. Improves lung function & ...
Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...
Allied Market Research published a report, titled, "Dyspnea treatment Market - Global Opportunity Analysis and Industry ...
The United States has revealed price reductions for the second round of | The U.S. has revealed price reductions for the ...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the completion of its Phase IIa clinical study for 9MW1911, a self-developed ...
BAGUIO CITY (PIA) — The Baguio General Hospital and Medical Center (BGHMC) is encouraging individuals with persistent respiratory symptoms to go for early checkup to detect and prevent Chronic ...
The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under ...
The Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback